Journals

Conferences

Open Access Articles- Top Results for Pirbuterol

Pirbuterol

For other uses, see [[:Maxair (disambiguation)#REDIRECTmw:Help:Magic words#Other
This page is a soft redirect.Maxair]].
</th></tr>
Pirbuterol
200px
200px
Systematic (IUPAC) name
(RS)-6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
Clinical data
Trade names Maxair
AHFS/Drugs.com Consumer Drug Information
MedlinePlus a601096
  • C
Inhalational
Identifiers
38029-10-6 7pxN
R03AC08 R03CC07
PubChem CID 4845
DrugBank DB01291 7pxY
ChemSpider 4679 7pxY
UNII OG645J8RVW 7pxY
KEGG D08387 7pxN
ChEMBL CHEMBL1094966 7pxY
Chemical data
Formula C12H20N2O3
240.30 g/mol
300.3 g/mol (acetate)
 14pxN (what is this?)  (verify)

Pirbuterol (trade name: Maxair) is a beta-2 adrenergic bronchodilator used in the treatment of asthma, available (as pirbuterol acetate) as a breath-activated metered-dose inhaler ("autohaler").

Clinical use

  • Asthma - preventative/maintenance medicine
  • Asthma - "rescue" medicine for reversal of acute asthma attack

Mode of action

Further information: Beta2-adrenergic agonist

Adverse effects

Further information: Beta2-adrenergic agonist

Synthesis

References

  1. ^ W.E. Barth, U.S. Patent 3,700,681 (1972).
  2. ^ W. Barth, U.S. Patent 3,763,173 (1973).
  3. ^ W. Barth, U.S. Patent 3,772,314 (1973).
  4. ^ W. Barth, U.S. Patent 3,786,160 (1974).
  5. ^ S. Nakanishi, U.S. Patent 3,948,919 (1976).
  6. ^ S. Nakanishi, U.S. Patent 4,031,108 (1977).
  7. ^ W.E. Barth, DE 2204195  (1972).

External links


Lua error in package.lua at line 80: module 'Module:Buffer' not found.